CYP2J2 and atrial fibrillation: Westphal et al16 firstly reported that transgenic mice with cardiomyocyte‐specific overexpression of CYP2J2 enhanced cardiac EET biosynthesis, reducing ventricular tachyarrhythmia and AF susceptibility during maladaptive cardiac hypertrophy.